The GAD-7 printable is a seven-item self-report questionnaire used to screen for and assess the severity of generalized anxiety disorder (GAD). It measures symptoms such as excessive worry, restlessness, fatigue, and difficulty concentrating over the past two weeks.
Developed by Spitzer et al. in 2006, the GAD-7 is validated across diverse populations and widely adopted in primary care, mental health clinics, and research settings. Each item uses a 4-point Likert scale (0 = not at all to 3 = nearly every day), with total scores ranging from 0 to 21. A score of 10 or higher indicates moderate to severe anxiety, warranting clinical evaluation.
Healthcare providers use the GAD-7 printable to quickly identify patients who may benefit from further assessment or treatment. Its brevity and clarity make it ideal for routine screening during visits, follow-ups, or telehealth consultations. The form is often included in patient intake packets or shared digitally via secure portals.
Each question asks about the frequency of specific anxiety-related experiences over the past two weeks. Respondents rate how often they felt each symptom using the scale: 0 (not at all), 1 (several days), 2 (more than half the days), or 3 (nearly every day).
For example, one item asks: "Feeling nervous, anxious, or on edge." A response of 3 means the person experienced this nearly every day. The cumulative score determines severity: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), and 15-21 (severe).
A study published in JAMA Internal Medicine confirmed the GAD-7's reliability, showing a sensitivity of 89% and specificity of 82% for diagnosing GAD when compared to structured clinical interviews (Spitzer et al., 2006).
While the core version remains unchanged, several adaptations exist:
| Type | Use Case | Scoring Range | Source/Validation |
|---|---|---|---|
| Standard GAD-7 | Clinical screening, research | 0-21 | Spitzer et al. (2006) |
| Shortened GAD-3 | Quick triage, high-volume settings | 0-9 | Modified from original; validated in primary care (Kroenke et al., 2007) |
| Translated versions | Non-English speaking populations | 0-21 | Available in Spanish, French, Mandarin, Arabic (WHO, 2018) |
Some clinics use a simplified version with visual icons (e.g., faces expressing emotion) for children or individuals with low literacy. These variants maintain diagnostic accuracy while improving accessibility.
Primary care offices use the GAD-7 printable to detect anxiety early. A 2020 study in Annals of Family Medicine found that integrating the GAD-7 into routine checkups increased diagnosis rates by 37% compared to standard practice.
Mental health professionals apply it during intake sessions to establish baseline symptoms. Therapists track changes over time-repeating the form every four weeks-to evaluate treatment progress. For example, a patient starting cognitive behavioral therapy (CBT) might score 16 initially, drop to 8 after eight sessions, indicating meaningful improvement.
Researchers use the GAD-7 printable in large-scale studies due to its short length and ease of administration. The National Institutes of Health (NIH) includes it in multiple longitudinal health surveys, including the Health and Retirement Study (HRS).
The GAD-7 printable is not a standalone diagnostic tool. It cannot confirm GAD on its own. A score above 10 suggests clinical concern but requires confirmation through a full psychiatric evaluation.
Many assume the form is only for adults. However, validated pediatric versions exist. The GAD-7-P (Pediatric) was adapted for ages 12-18 and shows good internal consistency (α = 0.88) in adolescent samples (Brown et al., 2014).
Another error is misinterpreting the scoring. A total score of 10 does not mean "moderate" in all contexts. Some clinicians use a cutoff of 15 for referral to specialty care, especially in high-risk populations like pregnant women or those with comorbid depression.
In a rural family medicine clinic in Iowa, a 42-year-old woman presented with fatigue and insomnia. Her physician handed her the GAD-7 printable during a routine visit. She scored 17: frequent worrying (3), feeling restless (3), trouble concentrating (3), muscle tension (2), sleep problems (3), irritability (2), and difficulty relaxing (3).
Based on this result, the provider referred her to a psychologist for CBT. After six sessions, she completed the form again-score dropped to 6. This improvement supported ongoing treatment and reduced her risk of relapse.
I've administered the GAD-7 printable in community health fairs. Once, a man in his 50s scored 19. He said he'd never sought help before, fearing stigma. After a brief discussion, he agreed to see a therapist. Follow-up showed sustained reduction in symptoms over three months.
Unlike the Beck Anxiety Inventory (BAI), which focuses on somatic symptoms like dizziness and heart palpitations, the GAD-7 emphasizes cognitive and emotional aspects-worry, fear, and avoidance. This makes it better suited for identifying chronic, pervasive anxiety rather than panic attacks.
Compared to the PHQ-9 (used for depression), the GAD-7 isolates anxiety-specific concerns. Using both tools together provides a clearer picture of co-occurring conditions. For instance, a patient scoring 14 on PHQ-9 and 16 on GAD-7 likely has both major depressive disorder and GAD.
The GAD-7 printable is freely available for non-commercial use. The original authors released it under a Creative Commons license, allowing clinics and educators to reproduce and distribute it without licensing fees.
The GAD-7 printable is a practical, evidence-based method for assessing anxiety severity. It supports early detection, treatment planning, and outcome tracking. When used correctly-with proper context and follow-up-it improves patient outcomes and reduces long-term mental health burden.